skip to main content
:::
:::

Special Report

Navigating the Future of Innovations

Panelists discussed blue ocean opportunities of Taiwan’s industry.

Panelists discussed blue ocean opportunities of Taiwan’s industry.

The panel discussion was centered on how industrial co-creation can lead to blue ocean opportunities in Taiwan. ITRI President Dr. Edwin Liu first shared his vision on the trend of future technology. He said that recent natural disasters show that humans can never win against Mother Nature, so we must learn to co-exist with the environment and move towards a self-sustaining community. According to Dr. Liu, sustainability will be crucial, which involves the development of shared economy, circular economy, renewable energy, and AI. He also pointed out that instead of focusing on strengthening the system, we should work on the resilience of the system, i.e. not to build a system that will never fail, but a system that can recover very fast.

When asked about possible collaborations with Taiwan or ITRI, Dr. Deepu Talla, Vice President & General Manager of Autonomous Machines, NVIDIA Corporation, remarked that ITRI has many researchers working in all sorts of fields, and the institute has cross-discipline research and works closely with industries. Some areas for joint contributions include autonomous vehicles, factory automation, robotics, and smart cities.

Mr. Seizo Onoe, Chief Technology Architect of NTT DOCOMO INC. and President of DOCOMO Technology Inc., expressed that Taiwan is a good place for innovations, and ITRI can help expand the existing strong industries. Mr. Onoe also mentioned his dream: to set up a network of microservice mobile bases with millimeter waves. He admitted that while it is theoretically possible, there are still many hurdles before the actual implementation of this project; therefore he looks forward to DOCOMO’s collaboration with ITRI and Taiwanese companies to come up with solutions.

Dr. Rajiv Rana, Head Medical Affairs Asia Pacific at Merck Group, explained that current collaborations between Merck and ITRI are mostly in the biopharma manufacturing arena. Through the partnership, Merck brings training, technology, devices, and international speakers to Taiwan, allowing it to build local capability. Other partnership opportunities are in research infrastructure, which has grown significantly in the last five years. In terms of cancer research, Taiwan has the advantage of having bio banks and huge databases, which can speed up the entire drug discovery process.

Dr. Gautam Meda, Division Vice President and Director, Modeling and Computational Science, Corning Research & Development Corporation, added some advantages of collaborating with Taiwan. He mentioned that Taiwan has a very well-educated and well-trained workforce. The researchers are very comfortable working internationally, and organizations like ITRI have a long-term focus, which will benefit the production of cooperative R&D results.

TOP